Sanofi

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch Sanofi and buy or sell other stocks, ETFs, and their options commission-free!

About SNY

Sanofi engages in the research, production, and distribution of pharmaceutical products. It operates through the Biopharma segment, which comprises commercial operations and research, development and production activities relating to the specialty care, general medicines and vaccines franchises plus support and corporate functions, for all geographical territories. 

CEO
Belén Garijo López
CEOBelén Garijo López
Employees
76,493
Employees76,493
Headquarters
Paris, Ile-de-France
HeadquartersParis, Ile-de-France
Founded
1994
Founded1994
Employees
76,493
Employees76,493

SNY Key Statistics

Market cap
103.84B
Market cap103.84B
Price-Earnings ratio
18.64
Price-Earnings ratio18.64
Dividend yield
3.93%
Dividend yield3.93%
Average volume
3.96M
Average volume3.96M
High today
$43.20
High today$43.20
Low today
$42.48
Low today$42.48
Open price
$43.02
Open price$43.02
Volume
2.94M
Volume2.94M
52 Week high
$52.68
52 Week high$52.68
52 Week low
$40.89
52 Week low$40.89

SNY News

The Wall Street Journal 1d
Health Care Roundup: Market Talk

Yves Herman / Reuters The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET and 16:50 ET....

Health Care Roundup: Market Talk
Benzinga 2d
Sanofi Says Weak Decision-Making Hurt Pipeline, Promises More Disciplined R&D

Dupixent Drives Growth While Vaccines Sales Decline Dupixent sales increased by 37.6% to 5.154 billion euros, above 5 billion euros per quarter for the first t...

Sanofi Says Weak Decision-Making Hurt Pipeline, Promises More Disciplined R&D
TipRanks 2d
Sanofi Publishes 2026 Half-Year Financial Report for Investors

Unlock powerful investing tools with TipRanks Premium to make smarter, more confident investment decisions Subscribe to TipRanks Smart Investor Newsletter, and...

Analyst ratings

50%

of 8 ratings
Buy
50%
Hold
50%
Sell
0%

More SNY News

TipRanks 2d
Sanofi Stock Slips As Key Trial Gets Suspended - TipRanks

...

Sanofi Stock Slips As Key Trial Gets Suspended - TipRanks
Nasdaq 2d
Sanofi Q2 Earnings Call Highlights

Sanofi (NASDAQ:SNY) raised its 2026 outlook after reporting double-digit second-quarter sales and earnings growth, driven by Dupixent, recently launched medicin...

Sanofi Q2 Earnings Call Highlights
TipRanks 2d
Sanofi reports Q2 business EPS EUR 2.09, up 31.4% reported

Business EPS was EUR 2.09, up by 33.3% at CER; 31.4% at actual exchange rates; IFRS EPS EUR 0.29. Reports net sales EUR 11.6B, up 16% reported and 17.8% at CER....

Nasdaq 2d
Sanofi Q2 Net Profit Plunges, Business Profit Climbs On Strong Sales; Lifts FY26 Outlook

(RTTNews) - French drug major Sanofi SA (SNY, SNYNF, SAN.PA) reported Thursday sharply lower net profit in its second quarter, while business earnings climbed f...

Sanofi Q2 Net Profit Plunges, Business Profit Climbs On Strong Sales; Lifts FY26 Outlook
The Wall Street Journal 3d
Sanofi Raises Guidance as New CEO Looks to Revamp Drug Pipeline

The guidance increase come less than two months after Belen Garijo became Sanofi’s CEO. Bloomberg News Sanofi SAN 0.68 %increase; up pointing triangle raised i...

Sanofi Raises Guidance as New CEO Looks to Revamp Drug Pipeline
TipRanks 3d
Sanofi’s MenQuadfi Safety Study in Korea: What Investors Should Watch

Sanofi SA (SNY) announced an update on their ongoing clinical study. Unlock powerful investing tools with TipRanks Premium to make smarter, more confident inve...

TipRanks 3d
Sanofi’s Sarclisa Real‑World Data: What the Latest Multiple Myeloma Update Means for Investors

Sanofi (SNYNF) announced an update on their ongoing clinical study. Unlock powerful investing tools with TipRanks Premium to make smarter, more confident inves...

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.